FMR LLC 13D and 13G filings for Vaxcyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:34 am Sale | 2024-12-31 | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 13,054,145 10.500% | -2,692,522 (-17.10%) | Filing |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 15,746,667 12.837% | 1,533,302 (+10.79%) | Filing |
| 2024-02-09 10:05 am Purchase | 2024-02-08 | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 14,213,365 14.937% | 4,044,084 (+39.77%) | Filing |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 10,169,281 12.875% | 2,294,931 (+29.14%) | Filing |
| 2022-02-09 10:01 am Purchase | 2022-02-08 | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 7,874,350 14.917% | 231,945 (+3.03%) | Filing |
| 2021-02-08 10:35 am Purchase | 2021-02-05 | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 7,642,405 14.999% | 1,972,357 (+34.79%) | Filing |
| 2020-08-10 09:25 am Purchase | 2020-08-07 | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 5,670,048 11.177% | 5,670,048 (New Position) | Filing |